Fri. 09/28
Session F.10 / OS Organhall / 10.30 - 12.30 am
Clinical Dialysis 2
Chairman 1: Ivanovich, / Chairman 2: J. Fort Ros, Barcelona Spain

10.30 - 10.45 am  O100 Hemofiltration with endogenous reinfusion (HFR): viable therapy to enhance middle and large molecular size solute removal
J. Fort Ros, Barcelona, Spain
10.45 - 11.00 am  O101 Does the daily sodium intake influence mortality in dialysis patients?
G. Severova- Andreevska, Skopje, Macedonia
11.00 - 11.15 am  O102 Retracted
11.15 - 11.30 am  O103 Impact on heparin dosage and compatibility using a citrate enriched dialysate in high-flux dialysis
W. Paetow, Rostock, Germany
11.30 - 11.45 am  O104

Microembolies of air are deposited in the lungs of haemodialysis patients
T. Braennstroem, Umea, Sweden

11.45 - 12.00 am  O105 Acetate free Hemodialysis
A. Amore, Torino, Italy
12.00 - 12.15 am  O106 HOW IMPORTANT IS THE DIALSATE FLOW DURING HEMODIALYSIS TREATMENTS
P. Ahrenholz, Rostock, Germany
12.15 - 12.30 am  O107 Clotting factors in patients with end stage renal disease
P. Dejanov, Skopje, Macedonia